Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Profit downgrade resets base

Monash IVF
3:27pm
May 20, 2025
MVF has downgraded its FY25 NPAT guidance by ~10% to $27.5m (from $30-31m), driven by softer market conditions in March and further deterioration in April. Following the incident involving the incorrect transfer of an embryo at one of its Brisbane clinics, MVF has not seen any material changes in new patient registrations, returning registrations or transfers across its domestic operations. We see this as positive, although we think the lack of news around the outcome of the independent review has weighed (and will continue to weigh) on the stock. Despite the incident, we think that taking a longer term view, MVF will work through any reputational brand damage, we think the fundamentals are sound and see the industry well placed for structural growth of which MVF will take a share. MVF is trading on ~10x FY26F P/E, with a ~7% dividend yield, we see this as too cheap and have upgraded to a Speculative Buy (from HOLD).

Model update: ACCC approval of Citywide acquisition

Cleanaway Waste Management
3:27pm
May 20, 2025
We update our model for inclusion of the Citywide Waste acquisition following ACCC approval of the acquisition that was first announced in June 2024. We view the acquisition as partly defensive (protects the future earnings of CWY’s landfill) and partly growth-oriented (planned expansion of acquired transfer station capacity). While we see little earnings accretion in the short term due to the incremental funding costs and reduced asset earnings during the period of transfer station redevelopment the acquisition returns are delivered over a long period. 12 month target price +3 cps to $2.98/sh. ADD retained, with 12 month potential TSR of c.12% (incl. cash yield of c.2%) and a 5-year potential IRR of c.11% pa.

Bulletproof through the cycle lows

New Hope Group
3:27pm
May 20, 2025
3Q earnings missed our forecasts modestly on lower prices and slightly lower volumes. We like the strong protection offered by Bengalla’s market leading cost structure and NHC’s large net cash position. We think that physical coal markets have bottomed and that NHC offers the safest exposure to accumulate ahead of the next coal price cycle. NHC remains too cheap, but does suit patient/ value investors, particularly as catalysts through the coming shoulder season for thermal coal look limited.

Oropesa, Spain, is the tin flagship

Elementos
3:27pm
May 19, 2025
Strong demand growth is anticipated for tin with the move to electrification, and with supply constraints enhanced by the geopolitical situation, and the appropriate environmental, social and governance (ESG) focus on mining and processing. The definitive feasibility study (DFS), released after meeting the relevant regulatory approvals, confirms a robust project, with a US$156M capital cost and an all-in sustaining cost of US$15,000/t Sn, with a projected long-term US$30,000/t tin price – the current tin price is US$32,574/t (May 2025). Primary applications required to deliver the DFS were submitted in line with the understandings reached with various arms of Administration. There remains a risk that the conditions of the final approvals may be unacceptable to Elementos. We value ELT shares at A$0.50ps, with a Target Price of A$0.30ps, both for the first time, based on the current bid for Atlantic Tin (75% of the Achmmach tin deposit). We move from Not Rated to Speculative Buy.

Upgrade cycle

Monadelphous Group
3:27pm
May 16, 2025
Following today’s contract awards ($180m with ~$60m E&C) we’ve become increasingly confident that MND will achieve >$1bn in E&C revenue in FY26 (vs consensus $946m). This, coupled with more oil & gas construction work, which tends to attract a higher margin due to technical complexities, leaves MND well poised to deliver better than expected earnings in FY26 (MorgansF NPAT +5% vs consensus). It’s too early to forecast FY27 with precision, though the medium-term outlook is rosy given the strong iron ore pipeline out to 2030, which may keep the upgrade cycle continuing for some time. We leave our FY25 forecasts unchanged but increase our FY26-27 NPAT by +4-5% as we incorporate additional E&C revenue as well as incremental earnings from the recent acquisition of High Energy Service. Our price target increases to $19.50 (from $17.50).

Glass market remains subdued

Orora
3:27pm
May 16, 2025
ORA hosted an investor day which included a trading and strategy update as well as a tour of its Dandenong Cans manufacturing facility. Overall, the trading update was softer (approx. -3% at the FY25 EBIT line) than our expectations and management’s guidance provided in February. We adjust FY25/26/27F EBIT by -3%/-4%/-1%. Our target price decreases to $2.03 (from $2.32 previously) on the back of the changes to earnings forecasts and a lower FY26F PE valuation multiple of 15x (from 16.5x previously) due to the weaker-than-expected trading update and the ongoing soft operating outlook (particularly in the glass businesses). Hold rating maintained. We prefer Amcor (AMC) (Add rating, $16.00 TP) in the Packaging sector.

1H25 earnings: A rare slip at the top

Aristocrat Leisure
3:27pm
May 16, 2025
Aristocrat Leisure’s (ALL) 1H25 result had the potential to be a messy one, following the Plarium divestment and limited visibility on the nascent Interactive unit. What we did not foresee was a ~5% shortfall in the core land-based division vs MorgansF and consensus expectations, caused by softer leased FPD and adverse mix in North America. ALL has a proven record of delivering on result day; however, with the shares trading at more than twice its closest peer multiple, even a modest earnings dip is severely punished by the market. Shares were down as much as 15% intraday but have steadily recovered since. Despite the miss, we see no structural change in market dynamics and regard the weakness as a short-term timing and mix issue. Importantly, management reiterated its qualitative guidance of constant currency NPATA growth in FY25 (MorgansF:~4%). Following the result, our FY26-27F EPSA estimates reduce by 6-7 %. We reiterate our Add rating and our 12-month target price reduces to $71 (previously $74).

Not the leverage it once had to a big crop

GrainCorp
3:27pm
May 15, 2025
GNC’s 1H25 result beat consensus estimates. Whilst GNC benefitted from a big crop (third largest on record), its earnings leverage was less than in recent years due to below average grain trading margins and lower crush margins. A large core cash position allowed GNC to reward shareholders with an attractive interim dividend and an upsized share buyback. A stronger than expected 1H25 has seen GNC upgrade its FY25 EBITDA and NPAT guidance by 3.4% and 3.2% at the new mid-point. The outlook for the FY26 winter crop is mixed with positive conditions in the north but the south is dry. We maintain a Hold rating with a new price target of A$8.20 (previously A$8.04).

North America is looking more promising

Xero
3:27pm
May 15, 2025
XRO’s result and outlook commentary were largely inline with expectations. For us, the highlights of the result was improved sales traction and tight cost management, which are supportive of accelerated investment in growth. We upgrade our Target Price to A$215 and our rating to an Add (from Hold).

2025 Investor Day: FCF inflection point in sight

Alliance Aviation Services
3:27pm
May 15, 2025
For some time now, the market has been hesitant to rerate AQZ due to poor cashflow generation and rising debt levels as it has heavily invested in its business. AQZ’s inaugural Investor Day highlighted that leverage will peak in FY25 and is expected to reduce materially in FY26, with its net debt target well below our previous forecast and consensus. The targets imply AQZ will return to generating strong positive FCF in the range of A$65-115m driven by the sale of surplus E190 engines. Importantly, we see this level of FCF being sustainable into FY27 given AQZ will have completed its multi-year fleet expansion. Updated FY25 NPBT guidance, at the midpoint, was ~11% below previous expectations. Whilst this wasn’t a surprise given we were always expecting there to be some impact from Tropical Cyclone Alfred, the quantum of the downgrade was more than we were expecting. As AQZ’s fleet expansion draws to a close over the next 12 months, we think a strong rerating in its share price is highly likely. There are striking similarities to when AQZ’s share price increased ~400% over 2017-19 (declining leverage and improved FCF). AQZ is trading on a FY26 P/E and EV/EBITDA of 6.8x and 3.5x, which compares to pre-COVID (prior to its fleet expansion) of 13-15x and 5-6x.

News & Insights

Michael Knox, Chief Economist, reveals how the OECD and RBA’s outdated assumptions about global trade fail to account for China’s Marxist-Leninist economic strategies.

This morning, I was asked to discuss Sarah Hunter’s presentation from yesterday. Sarah, the Assistant Governor and Chief Economist at the Reserve Bank of Australia (RBA), delivered a detailed and competent discussion on the conventional view of tariffs’ impact on the international economy. She highlighted that tariffs typically increase inflation and reduce economic output, a perspective echoed by the OECD in a similar presentation overnight. Sarah’s analysis focused on the potential shocks tariffs could cause, particularly their effects on GDP and inflation.

Drawing on my experience as an Australian trade commissioner and my work in Australian embassies, I found her presentation particularly interesting. My background allowed me to bring specialist knowledge to the conversation, which I believe gave me an edge. Notably, I observed that the RBA seems to lack analysts closely tracking individual policymakers in the Trump administration, such as Scott Bessent, whose views on tariffs and competition differ from the general assumptions. The conventional view assumes a world of perfectly competitive countries adhering to international trade rules and unlikely to engage in conflict—a scenario that doesn’t align with the current global trade environment, especially between China and the United States.

China, operating as a Marxist-Leninist economy, aims to dominate global markets by building monopolies in areas like rare earths, nickel, copper, and other base metals. It maintains a managed exchange rate, despite promises to the International Monetary Fund for a freely floating currency. If China allowed its currency, the RMB, to float, it would likely appreciate significantly, increasing imports and reducing its trade surplus. This would create a more balanced international trade environment, potentially reducing the need for other countries to impose tariffs. However, major institutions like the OECD and RBA seem to misjudge the nature of this trade shock, relying on outdated assumptions about global trade dynamics.

The international community also appears to overlook specific U.S. policy intentions, such as those articulated by figures like Peter Navarro and Scott Bessent. The U.S. aims to use tariffs selectively to bolster industries like pharmaceuticals, precision manufacturing, and motor vehicles. This misunderstanding leads public institutions to perceive unspecified risks, as reflected in Sarah’s otherwise able presentation. Because the RBA and similar institutions view the world as fraught with undefined risks, they are inclined to keep interest rates low, responding to perceived threats rather than an equilibrium model.

Interestingly, data from the U.S. economy contradicts the expected negative impacts of tariffs. The Chicago Fed National Activity Indicator, a reliable gauge of economic growth since the 2008 financial crisis, shows U.S. growth above the long-term trend for the first four months of this year. This suggests resilience despite tariff-related shocks. Ideally, growth will slow later this year, prompting the Federal Reserve to cut rates, facilitating a soft landing and a decline in the U.S. dollar to boost global commodity prices. However, this nuanced outlook wasn’t evident in yesterday’s presentation.

Moreover, the anticipated rise in U.S. inflation due to tariffs isn’t materialising. Scott Bessent recently noted that U.S. CPI inflation is lower than expected, with core inflation shown as the (16% trimmed mean) at 3% for the past two months . Core inflation  excluding  food and energy CPI  is only at 2.8%. This suggests that Chinese suppliers are absorbing tariff costs to maintain market share, rather than passing them on as higher prices. Recent Chinese data supports this, showing a slight decline in manufacturing confidence and coal consumption, indicating reduced factory output and electricity use. This points to a modest slowdown in China’s economy. So far the expected negative effects on U.S. prices and output are not occurring.

In summary, the fears expressed by institutions like the RBA and OECD about the Trump administration’s trade policies appear overstated. The U.S. economy is not experiencing the predicted declines in output or increases in inflation. While these effects may emerge later, the current data suggests that the risks are not as severe as anticipated, highlighting a disconnect between theoretical models and real-world outcomes.

Read more
Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more